Key regulatory milestones and financial updates position Sangamo Therapeutics Inc (SGMO) for potential growth despite funding ...

The Hillsboro Herald regularly tracks the happenings at Hillsboro City Hall, at least to the best of our ability we ...

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today reported business highlights and third quarter 2024 financial results. "This is ...

People inherit two copies of each gene -; one from each parent -; an evolutionary fail-safe to ensure survival even when one of them doesn't function.

Nykode Therapeutics (VACBF) announced last night that it has received notification from Genentech, a member of the Roche (RHHBY), of its ...

Roche’s Genentech is ending a partnership with Nykode Therapeutics that centered around a clinical-stage cancer vaccine ...

Revenue: Total revenue was $26.1 million for the third quarter of 2024, compared to $10.5 million for the third quarter of ...

Conjunctival breach and a late onset are common in cases of endophthalmitis associated with implantation of an anti-VEGF delivery device.

Genentech to Present New and Encouraging Long-term Follow-up Data Across Broad Hematology Portfolio at ASH 2024 ...